Last reviewed · How we verify
TC-N201 cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
TC-N201 cells (TC-N201 cells) — TCRCure Biopharma Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TC-N201 cells TARGET | TC-N201 cells | TCRCure Biopharma Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TC-N201 cells CI watch — RSS
- TC-N201 cells CI watch — Atom
- TC-N201 cells CI watch — JSON
- TC-N201 cells alone — RSS
Cite this brief
Drug Landscape (2026). TC-N201 cells — Competitive Intelligence Brief. https://druglandscape.com/ci/tc-n201-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab